SIGNIFICANCE: The molecular events that promote the development of pulmonary hypertension (PH) are complex and incompletely understood. The complex interplay between the pulmonary vasculature and its immediate microenvironment involving cells of immune system (i.e., macrophages) promotes a persistent inflammatory state, pathological angiogenesis, and fibrosis that are driven by metabolic reprogramming of mesenchymal and immune cells. Recent Advancements: Consistent with previous findings in the field of cancer metabolism, increased glycolytic rates, incomplete glucose and glutamine oxidation to support anabolism and anaplerosis, altered lipid synthesis/oxidation ratios, increased one-carbon metabolism, and activation of the pentose phosphate pathway to support nucleoside synthesis are but some of the key metabolic signatures of vascular cells in PH. In addition, metabolic reprogramming of macrophages is observed in PH and is characterized by distinct features, such as the induction of specific activation or polarization states that enable their participation in the vascular remodeling process. CRITICAL ISSUES: Accumulation of reducing equivalents, such as NAD(P)H in PH cells, also contributes to their altered phenotype both directly and indirectly by regulating the activity of the transcriptional co-repressor C-terminal-binding protein 1 to control the proliferative/inflammatory gene expression in resident and immune cells. Further, similar to the role of anomalous metabolism in mitochondria in cancer, in PH short-term hypoxia-dependent and long-term hypoxia-independent alterations of mitochondrial activity, in the absence of genetic mutation of key mitochondrial enzymes, have been observed and explored as potential therapeutic targets. FUTURE DIRECTIONS: For the foreseeable future, short- and long-term metabolic reprogramming will become a candidate druggable target in the treatment of PH. Antioxid. Redox Signal. 28, 230-250.

Department of Biochemistry and Molecular Genetics University of Colorado Denver Colorado

Department of Mitochondrial Physiology Institute of Physiology Czech Academy of Sciences Prague Czech Republic

Department of Pediatric Gastroenterology University of Colorado Denver Colorado

Department of Pharmacology School of Medicine New York Medical College Valhalla New York

Developmental Lung Biology and Cardiovascular Pulmonary Research Laboratories University of Colorado Denver Colorado

Zobrazit více v PubMed

Alirol E. and Martinou JC. Mitochondria and cancer: is there a morphological connection? Oncogene 25: 4706–4716, 2006 PubMed

Alzoubi A, Toba M, Abe K, O'Neill KD, Rocic P, et al. . Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 304: H1708–H1718, 2013 PubMed

Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang J, et al. . Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334: 1278–1283, 2011 PubMed PMC

Aon MA, Cortassa S, and O'Rourke B. Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta 1797: 865–877, 2010 PubMed PMC

Archer SL, Huang J, Henry T, Peterson D, and Weir EK. A redox-based O2 sensor in rat pulmonary vasculature. Circ Res 73: 1100–1112, 1993 PubMed

Archer SL, Marsboom G, Kim GH, Zhang HJ, Toth PT, et al. . Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation 121: 2661–2671, 2010 PubMed PMC

Ashizawa K, Willingham MC, Liang CM, and Cheng SY. In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate. J Biol Chem 266: 16842–16846, 1991 PubMed

Asosingh K, Aldred MA, Vasanji A, Drazba J, Sharp J, et al. . Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am J Pathol 172: 615–627, 2008 PubMed PMC

Barman SA, Chen F, Su Y, Dimitropoulou C, Wang Y, et al. . NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling. Arterioscler Thromb Vasc Biol 34: 1704–1715, 2014 PubMed PMC

Bertero T, Oldham WM, Cottrill KA, Pisano S, Vanderpool RR, et al. . Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. J Clin Invest 126: 3313–3335, 2016 PubMed PMC

Bhattacharya M. Stiff discipline for cells in pulmonary hypertension. Sci Transl Med 8: 358ec154, 2016

Bleier L, Wittig I, Heide H, Steger M, Brandt U, and Dröse S. Generator-specific targets of mitochondrial reactive oxygen species. Free Radic Biol Med 78: 1–10, 2015 PubMed

Boehme J, Sun X, Tormos KV, Gong W, Kellner M, et al. . Pulmonary artery smooth muscle cell hyperproliferation and metabolic shift triggered by pulmonary overcirculation. Am J Physiol Heart Circ Physiol 311: H944–H957, 2016 PubMed PMC

Boland ML, Chourasia AH, and Macleod KF. Mitochondrial dysfunction in cancer. Front Oncol 3: 292, 2013 PubMed PMC

Bonnet S, Dumas-de-La-Roque E, Bégueret H, Marthan R, Fayon M, et al. . Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension. Proc Natl Acad Sci U S A 100: 9488–9493, 2003 PubMed PMC

Brand MD. The sites and topology of mitochondrial superoxide production. Exp Gerontol 45: 466–472, 2010 PubMed PMC

Buchakjian MR. and Kornbluth S. The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol 11: 715–727, 2010 PubMed

Bull TM, Coldren CD, Geraci MW, and Voelkel NF. Gene expression profiling in pulmonary hypertension. Proc Am Thorac Soc 4: 117–120, 2007 PubMed

Byun JS. and Gardner K. C-terminal binding protein: a molecular link between metabolic imbalance and epigenetic regulation in breast cancer. Int J Cell Biol 2013: 647975, 2013 PubMed PMC

Cai J, Pardali E, Sánchez-Duffhues G, and ten Dijke P. BMP signaling in vascular diseases. FEBS Lett 586: 1993–2002, 2012 PubMed

Carmeliet P. and Jain RK. Angiogenesis in cancer and other diseases. Nature 407: 249–257, 2000 PubMed

Cavasin MA, Stenmark KR, and McKinsey TA. Emerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series). Pulm Circ 5: 63–72, 2015 PubMed PMC

Champagne DP, Hatle KM, Fortner KA, D'Alessandro A, Thornton TM, et al. . Fine-tuning of CD8(+) T cell mitochondrial metabolism by the respiratory chain repressor MCJ dictates protection to influenza virus. Immunity 44: 1299–1311, 2016 PubMed PMC

Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, and Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A 95: 11715–11720, 1998 PubMed PMC

Chaneton B, Hillmann P, Zheng L, Martin ACL, Maddocks ODK, et al. . Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491: 458–462, 2012 PubMed PMC

Chen C, Pore N, Behrooz A, Ismail-Beigi F, and Maity A. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem 276: 9519–9525, 2001 PubMed

Chen J, Sysol JR, Singla S, Zhao S, Yamamura A, et al. . Nicotinamide phosphoribosyltransferase promotes pulmonary vascular remodeling and is a therapeutic target in pulmonary arterial hypertension. Circulation 135: 1532–1546, 2017 PubMed PMC

Chettimada S, Gupte R, Rawat D, Gebb SA, McMurtry IF, and Gupte SA. Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 308: L287–L300, 2015 PubMed PMC

Chettimada S, Joshi SR, Alzoubi A, Gebb SA, McMurtry IF, et al. . Glucose-6-phosphate dehydrogenase plays a critical role in hypoxia-induced CD133+ progenitor cells self-renewal and stimulates their accumulation in the lungs of pulmonary hypertensive rats. Am J Physiol Lung Cell Mol Physiol 307: L545–L556, 2014 PubMed PMC

Chettimada S, Joshi SR, Dhagia V, Aiezza A, Lincoln TM, et al. . Vascular smooth muscle cell contractile protein expression is increased through protein kinase G-dependent and -independent pathways by glucose-6-phosphate dehydrogenase inhibition and deficiency. Am J Physiol Heart Circ Physiol 311: H904–H912, 2016 PubMed PMC

Chettimada S, Rawat DK, Dey N, Kobelja R, Simms Z, et al. . Glc-6-PD and PKG contribute to hypoxia-induced decrease in smooth muscle cell contractile phenotype proteins in pulmonary artery. Am J Physiol Lung Cell Mol Physiol 303: L64–L74, 2012 PubMed PMC

Chouchani ET, Pell VR, Gaude E, Aksentijević D, Sundier SY, et al. . Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515: 431–435, 2014 PubMed PMC

Christofk HR, Vander Heiden MG, Wu N, Asara JM, and Cantley LC. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452: 181–186, 2008 PubMed

Colegio OR, Chu N-Q, Szabo AL, Chu T, Rhebergen AM, et al. . Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513: 559–563, 2014 PubMed PMC

Cordes T, Wallace M, Michelucci A, Divakaruni AS, Sapcariu SC, et al. . Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J Biol Chem 291: 14274–14284, 2016 PubMed PMC

Cortassa S, O'Rourke B, and Aon MA. Redox-optimized ROS balance and the relationship between mitochondrial respiration and ROS. Biochim Biophys Acta 1837: 287–295, 2014 PubMed PMC

Cottrill KA. and Chan SY. Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect. Eur J Clin Invest 43: 855–865, 2013 PubMed PMC

Dahoui HA, Hayek MN, Nietert PJ, Arabi MT, Muwakkit SA, et al. . Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatr Blood Cancer 54: 398–402, 2010 PubMed

D'Alessandro A, Moore HB, Moore EE, Wither M, Nemkov T, et al. . Early hemorrhage triggers metabolic responses that build up during prolonged shock. Am J Physiol Regul Integr Comp Physiol 308: R1034–R1044, 2015 PubMed PMC

D'Alessandro A, Slaughter AL, Peltz ED, Moore EE, Silliman CC, et al. . Trauma/hemorrhagic shock instigates aberrant metabolic flux through glycolytic pathways, as revealed by preliminary 13C-glucose labeling metabolomics. J Transl Med 13: 253, 2015 PubMed PMC

Dang L, White DW, Gross S, Bennett BD, Bittinger MA, et al. . Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 465: 966, 2010 PubMed PMC

DeBerardinis RJ, Lum JJ, Hatzivassiliou G, and Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7: 11–20, 2008 PubMed

Demaria M. and Poli V. PKM2, STAT3 and HIF-1α: the Warburg's vicious circle. JAKSTAT 1: 194–196, 2012 PubMed PMC

Deschoemaeker S, Di Conza G, Lilla S, Martín-Pérez R, Mennerich D, et al. . PHD1 regulates p53-mediated colorectal cancer chemoresistance. EMBO Mol Med 7: 1350–1365, 2015 PubMed PMC

Díaz-Ruiz R, Avéret N, Araiza D, Pinson B, Uribe-Carvajal S, et al. . Mitochondrial oxidative phosphorylation is regulated by fructose 1,6-bisphosphate. A possible role in crabtree effect induction? J Biol Chem 283: 26948–26955, 2008 PubMed

Diebold I, Petry A, Hess J, and Görlach A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell 21: 2087–2096, 2010 PubMed PMC

Doherty JR. and Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest 123: 3685–3692, 2013 PubMed PMC

Dong G, Mao Q, Xia W, Xu Y, Wang J, et al. . PKM2 and cancer: the function of PKM2 beyond glycolysis. Oncol Lett 11: 1980–1986, 2016 PubMed PMC

Dromparis P, Paulin R, Sutendra G, Qi AC, Bonnet S, and Michelakis ED. Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension. Circ Res 113: 126–136, 2013 PubMed

Dromparis P, Sutendra G, and Michelakis ED. The role of mitochondria in pulmonary vascular remodeling. J Mol Med Berl Ger 88: 1003–1010, 2010 PubMed

Ducker GS. and Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab 25: 27–42, 2017 PubMed PMC

Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, et al. . Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115: 56–65, 2005 PubMed PMC

Dumas de La Roque E, Savineau J-P, Metivier A-C, Billes M-A, Kraemer J-P, et al. . Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study. Ann Endocrinol 73: 20–25, 2012 PubMed

El Kasmi KC, Anderson AL, Devereaux MW, Vue PM, Zhang W, et al. . Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease. Sci Transl Med 5: 206ra137, 2013 PubMed PMC

El Kasmi KC, Pugliese SC, Riddle SR, Poth JM, Anderson AL, et al. . Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension. J Immunol 193: 597–609, 2014 PubMed PMC

El Kasmi KC. and Stenmark KR. Contribution of metabolic reprogramming to macrophage plasticity and function. Semin Immunol 27: 267–275, 2015 PubMed PMC

Elliott CG, Barst RJ, Seeger W, Porres-Aguilar M, Brown LM, et al. . Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl): 85S–94S, 2010 PubMed

Erez A. and DeBerardinis RJ. Metabolic dysregulation in monogenic disorders and cancer—finding method in madness. Nat Rev Cancer 15: 440–448, 2015 PubMed

Fendt S-M, Bell EL, Keibler MA, Olenchock BA, Mayers JR, et al. . Reductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells. Nat Commun 4: 2236, 2013 PubMed PMC

Fessel JP, Hamid R, Wittmann BM, Robinson LJ, Blackwell T, et al. . Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming. Pulm Circ 2: 201–213, 2012 PubMed PMC

Fico A, Paglialunga F, Cigliano L, Abrescia P, Verde P, et al. . Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis. Cell Death Differ 11: 823–831, 2004 PubMed

Fijalkowska I, Xu W, Comhair SAA, Janocha AJ, Mavrakis LA, et al. . Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells. Am J Pathol 176: 1130–1138, 2010 PubMed PMC

Filosa S, Fico A, Paglialunga F, Balestrieri M, Crooke A, et al. . Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress. Biochem J 370(Pt 3): 935–943, 2003 PubMed PMC

Foley JF. The NADPH survival advantage. Sci Signal 5: ec156, 2012

Forgione MA. and Loscalzo J. Oxidant stress as a critical determinant of endothelial function. Drug News Perspect 13: 523–529, 2000 PubMed

Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604–4613, 1996 PubMed PMC

Francis SH, Busch JL, Corbin JD, and Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 62: 525–563, 2010 PubMed PMC

Freund-Michel V, Khoyrattee N, Savineau J-P, Muller B, and Guibert C. Mitochondria: roles in pulmonary hypertension. Int J Biochem Cell Biol 55: 93–97, 2014 PubMed

Frid MG, Brunetti JA, Burke DL, Carpenter TC, Davie NJ, et al. . Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 168: 659–669, 2006 PubMed PMC

Gameiro PA, Laviolette LA, Kelleher JK, Iliopoulos O, and Stephanopoulos G. Cofactor balance by nicotinamide nucleotide transhydrogenase (NNT) coordinates reductive carboxylation and glucose catabolism in the tricarboxylic acid (TCA) cycle. J Biol Chem 288: 12967–12977, 2013 PubMed PMC

Gao X, Wang H, Yang JJ, Liu X, and Liu Z-R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 45: 598–609, 2012 PubMed PMC

Gerner EW. and Meyskens FL. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4: 781–792, 2004 PubMed

Gupte RS, Ata H, Rawat D, Abe M, Taylor MS, et al. . Glucose-6-phosphate dehydrogenase is a regulator of vascular smooth muscle contraction. Antioxid Redox Signal 14: 543–558, 2011 PubMed PMC

Gupte RS, Rawat DK, Chettimada S, Cioffi DL, Wolin MS, et al. . Activation of glucose-6-phosphate dehydrogenase promotes acute hypoxic pulmonary artery contraction. J Biol Chem 285: 19561–19571, 2010 PubMed PMC

Gupte SA, Kaminski PM, Floyd B, Agarwal R, Ali N, et al. . Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol 288: H13–H21, 2005 PubMed

Gupte SA, Li K-X, Okada T, Sato K, and Oka M. Inhibitors of pentose phosphate pathway cause vasodilation: involvement of voltage-gated potassium channels. J Pharmacol Exp Ther 301: 299–305, 2002 PubMed

Hampl V, Bíbová J, Povýsilová V, and Herget J. Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats. Eur Respir J 21: 862–865, 2003 PubMed

Hanahan D. and Weinberg RA. Hallmarks of cancer: the next generation. Cell 144: 646–674, 2011 PubMed

Hatle KM, Gummadidala P, Navasa N, Bernardo E, Dodge J, et al. . MCJ/DnaJC15, an endogenous mitochondrial repressor of the respiratory chain that controls metabolic alterations. Mol Cell Biol 33: 2302–2314, 2013 PubMed PMC

Hirschey MD, DeBerardinis RJ, Diehl AME, Drew JE, Frezza C, et al. . Dysregulated metabolism contributes to oncogenesis. Semin Cancer Biol 35 Suppl: S129–S150, 2015 PubMed PMC

Hitosugi T, Fan J, Chung T-W, Lythgoe K, Wang X, et al. . Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell 44: 864–877, 2011 PubMed PMC

Huberts DHEW. and van der Klei IJ. Moonlighting proteins: an intriguing mode of multitasking. Biochim Biophys Acta 1803: 520–525, 2010 PubMed

Hue L. and Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 297: E578–E591, 2009 PubMed PMC

Huston JH. and Ryan JJ. The emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference series). Pulm Circ 6: 274–284, 2016 PubMed PMC

Imtiyaz HZ. and Simon MC. Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345: 105–120, 2010 PubMed PMC

Intlekofer AM, Dematteo RG, Venneti S, Finley LWS, Lu C, et al. . Hypoxia induces production of l-2-hydroxyglutarate. Cell Metab 22: 304–311, 2015 PubMed PMC

Intlekofer AM, Wang B, Liu H, Shah H, Carmona-Fontaine C, et al. . L-2-hydroxyglutarate production arises from noncanonical enzyme function at acidic pH. Nat Chem Biol 13: 494–500, 2017 PubMed PMC

Jeon S-M, Chandel NS, and Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485: 661–665, 2012 PubMed PMC

Jha AK, Huang SC-C, Sergushichev A, Lampropoulou V, Ivanova Y, et al. . Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42: 419–430, 2015 PubMed

Karimi Galougahi K, Ashley EA, and Ali ZA. Redox regulation of vascular remodeling. Cell Mol Life Sci 73: 349–363, 2016 PubMed PMC

Kelly B, Tannahill GM, Murphy MP, and O'Neill LAJ. Metformin inhibits the production of reactive oxygen species from NADH:ubiquinone oxidoreductase to limit induction of interleukin-1β (IL-1β) and boosts interleukin-10 (IL-10) in lipopolysaccharide (LPS)-activated macrophages. J Biol Chem 290: 20348–20359, 2015 PubMed PMC

Kim GH, Ryan JJ, Marsboom G, and Archer SL. Epigenetic mechanisms of pulmonary hypertension. Pulm Circ 1: 347–356, 2011 PubMed PMC

Kim J, Tchernyshyov I, Semenza GL, and Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3: 177–185, 2006 PubMed

Kim JH. and Youn HD. C-terminal binding protein maintains mitochondrial activities. Cell Death Differ 16: 584–592, 2009 PubMed

Kincaid B. and Bossy-Wetzel E. Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration. Front Aging Neurosci 5: 48, 2013 PubMed PMC

Kirkman HN, Rolfo M, Ferraris AM, and Gaetani GF. Mechanisms of protection of catalase by NADPH kinetics and stoichiometry. J Biol Chem 274: 13908–13914, 1999 PubMed

Koivunen P, Hirsilä M, Remes AM, Hassinen IE, Kivirikko KI, and Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of hif. J Biol Chem 282: 4524–4532, 2007 PubMed

Kotas ME. and Medzhitov R. Homeostasis, inflammation, and disease susceptibility. Cell 160: 816–827, 2015 PubMed PMC

Kuroda J, Nakagawa K, Yamasaki T, Nakamura K, Takeya R, et al. . The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10: 1139–1151, 2005 PubMed

Labuschagne CF, van den Broek NJF, Mackay GM, Vousden KH, and Maddocks ODK. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep 7: 1248–1258, 2014 PubMed

Lakhkar A, Dhagia V, Joshi SR, Gotlinger K, Patel D, et al. . 20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase inhibition. Am J Physiol Heart Circ Physiol 310: H1107–H1117, 2016 PubMed PMC

Lapel M, Weston P, Strassheim D, Karoor V, Burns N, et al. . Glycolysis and oxidative phosphorylation are essential for purinergic receptor-mediated angiogenic responses in vasa vasorum endothelial cells. Am J Physiol Cell Physiol 312: C56–C70, 2017 PubMed PMC

Laurent G, de Boer VCJ, Finley LWS, Sweeney M, Lu H, et al. . SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation. Mol Cell Biol 33: 4552–4561, 2013 PubMed PMC

Lee DC, Sohn HA, Park Z-Y, Oh S, Kang YK, et al. . A lactate-induced response to hypoxia. Cell 161: 595–609, 2015 PubMed

Leopold JA, Walker J, Scribner AW, Voetsch B, Zhang Y-Y, et al. . Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J Biol Chem 278: 32100–32106, 2003 PubMed

Levine AJ. and Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330: 1340–1344, 2010 PubMed

Li M, Riddle SR, Frid MG, El Kasmi KC, McKinsey TA, et al. . Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. J Immunol 187: 2711–2722, 2011 PubMed PMC

Li M, Riddle S, Zhang H, D'Alessandro A, Flockton A, et al. . Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional corepressor C-terminal binding protein-1. Circulation 134: 1105–1121, 2016 PubMed PMC

Li S, Tabar SS, Malec V, Eul BG, Klepetko W, et al. . NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts. Antioxid Redox Signal 10: 1687–1698, 2008 PubMed

Liu H, Zhang Y, Wu H, D'Alessandro A, Yegutkin GG, et al. . Beneficial role of erythrocyte adenosine A2B receptor–mediated AMP-activated protein kinase activation in high-altitude hypoxiaclinical perspective. Circulation 134: 405–421, 2016 PubMed PMC

Liu JQ, Zelko IN, Erbynn EM, Sham JSK, and Folz RJ. Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). Am J Physiol Lung Cell Mol Physiol 290: L2–L10, 2006 PubMed

Locasale JW. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 13: 572–583, 2013 PubMed PMC

Luo W, Hu H, Chang R, Zhong J, Knabel M, et al. . Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145: 732–744, 2011 PubMed PMC

Luo W. and Semenza GL. Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells. Oncotarget 2: 551–556, 2011 PubMed PMC

Maddocks ODK, Berkers CR, Mason SM, Zheng L, Blyth K, et al. . Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493: 542–546, 2013 PubMed PMC

Maddocks ODK, Labuschagne CF, Adams PD, and Vousden KH. Serine metabolism supports the methionine cycle and DNA/RNA methylation through de novo ATP synthesis in cancer cells. Mol Cell 61: 210–221, 2016 PubMed PMC

Man K, Kutyavin VI, and Chawla A. Tissue immunometabolism: development, physiology, and pathobiology. Cell Metab 25: 11–26, 2017 PubMed PMC

Mannic T, Viguie J, and Rossier MF. In vivo and in vitro evidences of dehydroepiandrosterone protective role on the cardiovascular system. Int J Endocrinol Metab 13: e24660, 2015 PubMed PMC

Marelli-Berg FM, Fu H, and Mauro C. Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T-cell-mediated immunity. Immunology 136: 363–369, 2012 PubMed PMC

Marín-Hernández A, Gallardo-Pérez JC, Ralph SJ, Rodríguez-Enríquez S, and Moreno-Sánchez R. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 9: 1084–1101, 2009 PubMed

Marsboom G, Wietholt C, Haney CR, Toth PT, Ryan JJ, et al. . Lung 18F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. Am J Respir Crit Care Med 185: 670–679, 2012 PubMed PMC

Martinez-Outschoorn UE, Lisanti MP, and Sotgia F. Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin Cancer Biol 25: 47–60, 2014 PubMed

Mathupala SP, Ko YH, and Pedersen PL. The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies. Biochim Biophys Acta 1797: 1225–1230, 2010 PubMed PMC

McMurtry MS, Bonnet S, Wu X, Dyck JRB, Haromy A, et al. . Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 95: 830–840, 2004 PubMed

Mentch SJ. and Locasale JW. One-carbon metabolism and epigenetics: understanding the specificity. Ann N Y Acad Sci 1363: 91–98, 2016 PubMed PMC

Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, et al. . Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481: 380–384, 2011 PubMed PMC

Mills E. and O'Neill LAJ. Succinate: a metabolic signal in inflammation. Trends Cell Biol 24: 313–320, 2014 PubMed

Mills EL, Kelly B, Logan A, Costa ASH, Varma M, et al. . Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167: 457–470.e13, 2016 PubMed PMC

Mills EL. and O'Neill LA. Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal. Eur J Immunol 46: 13–21, 2016 PubMed

Minkin R, Sandhu G, Grosu H, Tartell L, Ma S, et al. . Desmosine and isodesmosine as a novel biomarker for pulmonary arterial hypertension: a pilot study. Am J Ther 2015. [Epub ahead of print]; DOI: 10.1097/MJT.0000000000000260 PubMed DOI

Miura G. Ischemia: succinate comes up roses. Nat Chem Biol 11: 3, 2015

Moon J-S, Hisata S, Park M-A, DeNicola GM, Ryter SW, et al. . mTORC1-induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation. Cell Rep 12: 102–115, 2015 PubMed PMC

Morgan JM, McCormack DG, Griffiths MJ, Morgan CJ, Barnes PJ, and Evans TW. Adenosine as a vasodilator in primary pulmonary hypertension. Circulation 84: 1145–1149, 1991 PubMed

Mu X, Zhao T, Xu C, Shi W, Geng B, et al. . Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation. Oncotarget 8: 13174–13185, 2017 PubMed PMC

Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1–13, 2009 PubMed PMC

Murray PJ. Macrophage polarization. Annu Rev Physiol 79: 541–566, 2017 PubMed

Murray PJ. and Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723–737, 2011 PubMed PMC

Nadtochiy SM, Schafer X, Fu D, Nehrke K, Munger J, and Brookes PS. Acidic pH is a metabolic switch for 2-hydroxyglutarate generation and signaling. J Biol Chem 291: 20188–20197, 2016 PubMed PMC

Navasa N, Martín I, Iglesias-Pedraz JM, Beraza N, Atondo E, et al. . Regulation of oxidative stress by methylation-controlled J protein controls macrophage responses to inflammatory insults. J Infect Dis 211: 135–145, 2015 PubMed PMC

Nguyen KD, Qiu Y, Cui X, Goh YPS, Mwangi J, et al. . Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480: 104–108, 2011 PubMed PMC

Nisimoto Y, Diebold BA, Cosentino-Gomes D, Constentino-Gomes D, and Lambeth JD. Nox4: a hydrogen peroxide-generating oxygen sensor. Biochemistry 53: 5111–5120, 2014 PubMed PMC

Nowotarski SL, Woster PM, and Casero RA. Polyamines and cancer: implications for chemoprevention and chemotherapy. Expert Rev Mol Med 15: e3, 2013 PubMed PMC

Nutt LK. The Xenopus oocyte: a model for studying the metabolic regulation of cancer cell death. Semin Cell Dev Biol 23: 412–418, 2012 PubMed

Oka M, Karoor V, Homma N, Nagaoka T, Sakao E, et al. . Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension. Cardiovasc Res 74: 377–387, 2007 PubMed PMC

Okabe Y. and Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 157: 832–844, 2014 PubMed PMC

Okabe Y. and Medzhitov R. Tissue biology perspective on macrophages. Nat Immunol 17: 9–17, 2016 PubMed

Oldham WM, Clish CB, Yang Y, and Loscalzo J. Hypoxia-mediated increases in L-2-hydroxyglutarate coordinate the metabolic response to reductive stress. Cell Metab 22: 291–303, 2015 PubMed PMC

Oliveira EC, Ribeiro ALP, and Amaral CFS. Adenosine for vasoreactivity testing in pulmonary hypertension: a head-to-head comparison with inhaled nitric oxide. Respir Med 104: 606–611, 2010 PubMed

O'Neill LAJ. A critical role for citrate metabolism in LPS signalling. Biochem J 438: e5–e6, 2011 PubMed

O'Neill LAJ, Kishton RJ, and Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol 16: 553–565, 2016 PubMed PMC

O'Neill LAJ. and Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med 213: 15–23, 2016 PubMed PMC

Orr AL, Quinlan CL, Perevoshchikova IV, and Brand MD. A refined analysis of superoxide production by mitochondrial sn-glycerol 3-phosphate dehydrogenase. J Biol Chem 287: 42921–42935, 2012 PubMed PMC

Ozden O, Park S-H, Wagner BA, Yong Song H, Zhu Y, et al. . SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells. Free Radic Biol Med 76: 163–172, 2014 PubMed PMC

Pagano G, Talamanca AA, Castello G, Cordero MD, d'Ischia M, et al. . Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies. Oxid Med Cell Longev 2014: 541230, 2014 PubMed PMC

Pak O, Sommer N, Hoeres T, Bakr A, Waisbrod S, et al. . Mitochondrial hyperpolarization in pulmonary vascular remodeling. mitochondrial uncoupling protein deficiency as disease model. Am J Respir Cell Mol Biol 49: 358–367, 2013 PubMed

Palazon A, Goldrath A, Nizet V, and Johnson RS. HIF transcription factors, inflammation, and immunity. Immunity 41: 518–528, 2014 PubMed PMC

Palsson-McDermott EM, Curtis AM, Goel G, Lauterbach MAR, Sheedy FJ, et al. . Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages. Cell Metab 21: 65–80, 2015 PubMed PMC

Pandey D, Patel A, Patel V, Chen F, Qian J, et al. . Expression and functional significance of NADPH oxidase 5 (Nox5) and its splice variants in human blood vessels. Am J Physiol Heart Circ Physiol 302: H1919–H1928, 2012 PubMed PMC

Parker SJ. and Metallo CM. Chasing one-carbon units to understand the role of serine in epigenetics. Mol Cell 61: 185–186, 2016 PubMed

Paulin R, Dromparis P, Sutendra G, Gurtu V, Zervopoulos S, et al. . Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans. Cell Metab 20: 827–839, 2014 PubMed

Paulin R. and Michelakis ED. The metabolic theory of pulmonary arterial hypertension. Circ Res 115: 148–164, 2014 PubMed

Pedersen PL. Voltage dependent anion channels (VDACS): a brief introduction with a focus on the outer mitochondrial compartment's roles together with hexokinase-2 in the “Warburg effect” in cancer. J Bioenerg Biomembr 40: 123–126, 2008 PubMed

Pell VR, Chouchani ET, Frezza C, Murphy MP, and Krieg T. Succinate metabolism: a new therapeutic target for myocardial reperfusion injury. Cardiovasc Res 111: 134–141, 2016 PubMed

Plecitá-Hlavatá L, Tauber J, Li M, Zhang H, Flockton AR, et al. . Constitutive reprogramming of fibroblast mitochondrial metabolism in pulmonary hypertension. Am J Respir Cell Mol Biol 55: 47–57, 2016 PubMed PMC

Prigione A, Rohwer N, Hoffmann S, Mlody B, Drews K, et al. . HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1–3 and PKM2. Stem Cells 32: 364–376, 2014 PubMed PMC

Pugliese SC, Poth JM, Fini MA, Olschewski A, El Kasmi KC, and Stenmark KR. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. Am J Physiol Lung Cell Mol Physiol 308: L229–L252, 2015 PubMed PMC

Pullamsetti SS, Perros F, Chelladurai P, Yuan J, and Stenmark K. Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series). Pulm Circ 6: 448–464, 2016 PubMed PMC

Qualls JE, Subramanian C, Rafi W, Smith AM, Balouzian L, et al. . Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1. Cell Host Microbe 12: 313–323, 2012 PubMed PMC

Quinlan CL, Orr AL, Perevoshchikova IV, Treberg JR, Ackrell BA, and Brand MD. Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J Biol Chem 287: 27255–27264, 2012 PubMed PMC

Rafikov R, Sun X, Rafikova O, Meadows ML, Desai AA, et al. . Complex I dysfunction underlies the glycolytic switch in pulmonary hypertensive smooth muscle cells. Redox Biol 6: 278–286, 2015 PubMed PMC

Rafikova O, Meadows ML, Kinchen JM, Mohney RP, Maltepe E, et al. . Metabolic changes precede the development of pulmonary hypertension in the monocrotaline exposed rat lung. PLoS One 11: e0150480, 2016 PubMed PMC

Randle PJ, Garland PB, Hales CN, and Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785–789, 1963 PubMed

Rapovy SM, Zhao J, Bricker RL, Schmidt SM, Setchell KDR, and Qualls JE. Differential requirements for L-citrulline and L-arginine during antimycobacterial macrophage activity. J Immunol 195: 3293–3300, 2015 PubMed PMC

Rathore R, Zheng Y-M, Li X-Q, Wang Q-S, Liu Q-H, et al. . Mitochondrial ROS-PKCepsilon signaling axis is uniquely involved in hypoxic increase in [Ca2+]i in pulmonary artery smooth muscle cells. Biochem Biophys Res Commun 351: 784–790, 2006 PubMed PMC

Rawat DK, Alzoubi A, Gupte R, Chettimada S, Watanabe M, et al. . Increased reactive oxygen species, metabolic maladaptation, and autophagy contribute to pulmonary arterial hypertension-induced ventricular hypertrophy and diastolic heart failure. Hypertension 64: 1266–1274, 2014 PubMed

Rhodes CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, Hadinnapola C, et al. . Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension. Circulation 135: 460–475, 2017 PubMed PMC

Robey IF, Lien AD, Welsh SJ, Baggett BK, and Gillies RJ. Hypoxia-inducible factor-1α and the glycolytic phenotype in tumors. Neoplasia 7: 324–330, 2005 PubMed PMC

Ryan J, Dasgupta A, Huston J, Chen K-H, and Archer SL. Mitochondrial dynamics in pulmonary arterial hypertension. J Mol Med (Berl) 93: 229–242, 2015 PubMed PMC

Sabharwal SS, Waypa GB, Marks JD, and Schumacker PT. Peroxiredoxin-5 targeted to the mitochondrial intermembrane space attenuates hypoxia-induced reactive oxygen species signalling. Biochem J 456: 337–346, 2013 PubMed PMC

Saco TV, Parthasarathy PT, Cho Y, Lockey RF, and Kolliputi N. Role of epigenetics in pulmonary hypertension. Am J Physiol Cell Physiol 306: C1101–C1105, 2014 PubMed PMC

Salminen A, Kaarniranta K, Hiltunen M, and Kauppinen A. Krebs cycle dysfunction shapes epigenetic landscape of chromatin: novel insights into mitochondrial regulation of aging process. Cell Signal 26: 1598–1603, 2014 PubMed

Sánchez-Caballero L, Guerrero-Castillo S, and Nijtmans L. Unraveling the complexity of mitochondrial complex I assembly: a dynamic process. Biochim Biophys Acta 1857: 980–990, 2016 PubMed

Santidrian AF, LeBoeuf SE, Wold ED, Ritland M, Forsyth JS, and Felding BH. Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer. DNA Repair 23: 79–87, 2014 PubMed PMC

Savai R, Pullamsetti SS, Kolbe J, Bieniek E, Voswinckel R, et al. . Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 186: 897–908, 2012 PubMed

Schwartz AG. and Pashko LL. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs. J Cell Biochem Suppl 22: 210–217, 1995 PubMed

Schwartz AG. and Pashko LL. Mechanism of cancer preventive action of DHEA. Role of glucose-6-phosphate dehydrogenase. Ann N Y Acad Sci 774: 180–186, 1995 PubMed

Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, et al. . Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7: 77–85, 2005 PubMed

Semenza GL. Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol 76: 347–353, 2011 PubMed

Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol 76: 39–56, 2014 PubMed PMC

Shim E-H, Livi CB, Rakheja D, Tan J, Benson D, et al. . L-2-hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov 4: 1290–1298, 2014 PubMed PMC

Shimoda LA. and Laurie SS. HIF and pulmonary vascular responses to hypoxia. J Appl Physiol (1985) 116: 867–874, 2014 PubMed PMC

Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, et al. . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62: D34–D41, 2013 PubMed

Slaughter AL, D'Alessandro A, Moore EE, Banerjee A, Silliman CC, et al. . Glutamine metabolism drives succinate accumulation in plasma and the lung during hemorrhagic shock. J Trauma Acute Care Surg 81: 1012–1019, 2016 PubMed PMC

Soda K. The mechanisms by which polyamines accelerate tumor spread. J Exp Clin Cancer Res 30: 95, 2011 PubMed PMC

Song A, Zhang Y, Han L, Yegutkin GG, Liu H, et al. . Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent. Nat Commun 8: 14108, 2017 PubMed PMC

Starkov AA, Fiskum G, Chinopoulos C, Lorenzo BJ, Browne SE, et al. . Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci 24: 7779–7788, 2004 PubMed PMC

Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, and Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 104: 236–244, 28p following 244, 2009 PubMed PMC

Stenmark KR, Tuder RM, and El Kasmi KC. Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension. J Appl Physiol (1985) 119: 1164–1172, 2015 PubMed PMC

Sun X, Kumar S, Sharma S, Aggarwal S, Lu Q, et al. . Endothelin-1 induces a glycolytic switch in pulmonary arterial endothelial cells via the mitochondrial translocation of endothelial nitric oxide synthase. Am J Respir Cell Mol Biol 50: 1084–1095, 2014 PubMed PMC

Sutendra G, Bonnet S, Rochefort G, Haromy A, Folmes KD, et al. . Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension. Sci Transl Med 2: 44ra58, 2010 PubMed

Sutendra G. and Michelakis ED. The metabolic basis of pulmonary arterial hypertension. Cell Metab 19: 558–573, 2014 PubMed

Talati M. and Hemnes A. Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy. Pulm Circ 5: 269–278, 2015 PubMed PMC

Tamada M, Suematsu M, and Saya H. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells. Clin Cancer Res 18: 5554–5561, 2012 PubMed

Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, et al. . Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496: 238–242, 2013 PubMed PMC

Tavana O. and Gu W. The hunger games: p53 regulates metabolism upon serine starvation. Cell Metab 17: 159–161, 2013 PubMed PMC

Tello D, Balsa E, Acosta-Iborra B, Fuertes-Yebra E, Elorza A, et al. . Induction of the mitochondrial NDUFA4L2 protein by HIF-1α decreases oxygen consumption by inhibiting complex I activity. Cell Metab 14: 768–779, 2011 PubMed

Treberg JR, Quinlan CL, and Brand MD. Evidence for two sites of superoxide production by mitochondrial NADH-ubiquinone oxidoreductase (complex I). J Biol Chem 286: 27103–27110, 2011 PubMed PMC

Tretter L. and Adam-Vizi V. Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase. J Neurosci 24: 7771–7778, 2004 PubMed PMC

Tretter L, Patocs A, and Chinopoulos C. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis. Biochim Biophys Acta 1857: 1086–1101, 2016 PubMed

Tuder RM, Archer SL, Dorfmüller P, Erzurum SC, Guignabert C, et al. . Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl): D4–D12, 2013 PubMed PMC

Tuder RM, Davis LA, and Graham BB. Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension. Am J Respir Crit Care Med 185: 260–266, 2012 PubMed PMC

Tuder RM. and Voelkel NF. Pulmonary hypertension and inflammation. J Lab Clin Med 132: 16–24, 1998 PubMed

Tzounakas VL, Kriebardis AG, Georgatzakou HT, Foudoulaki-Paparizos LE, Dzieciatkowska M, et al. . Glucose 6-phosphate dehydrogenase deficient subjects may be better “storers” than donors of red blood cells. Free Radic Biol Med 96: 152–165, 2016 PubMed

Valsecchi F, Grefte S, Roestenberg P, Joosten-Wagenaars J, Smeitink JAM, et al. . Primary fibroblasts of ndufs4(−/−) mice display increased ROS levels and aberrant mitochondrial morphology. Mitochondrion 13: 436–443, 2013 PubMed

Van den Bossche J, Baardman J, Otto NA, van der Velden S, Neele AE, et al. . Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep 17: 684–696, 2016 PubMed

Vander Heiden MG, Cantley LC, and Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029–1033, 2009 PubMed PMC

Veith C, Kraut S, Wilhelm J, Sommer N, Quanz K, et al. . NADPH oxidase 4 is not involved in hypoxia-induced pulmonary hypertension. Pulm Circ 6: 397–400, 2016 PubMed PMC

Ventetuolo CE, Baird GL, Barr RG, Bluemke DA, Fritz JS, et al. . Higher estradiol and lower dehydroepiandrosterone-sulfate levels are associated with pulmonary arterial hypertension in men. Am J Respir Crit Care Med 193: 1168–1175, 2016 PubMed PMC

Vergadi E, Chang MS, Lee C, Liang OD, Liu X, et al. . Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation 123: 1986–1995, 2011 PubMed PMC

Wang L, Zhou H, Wang Y, Cui G, and Di L-J. CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4. Cell Death Dis 6: e1620, 2015 PubMed PMC

Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, et al. . The transcription factor myc controls metabolic reprogramming upon t lymphocyte activation. Immunity 35: 871–882, 2011 PubMed PMC

Waypa GB, Guzy R, Mungai PT, Mack MM, Marks JD, et al. . Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells. Circ Res 99: 970–978, 2006 PubMed

Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, et al. . Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A 107: 8788–8793, 2010 PubMed PMC

Wellen KE. and Thompson CB. A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol 13: 270–276, 2012 PubMed

Westermann B. Bioenergetic role of mitochondrial fusion and fission. Biochim Biophys Acta 1817: 1833–1838, 2012 PubMed

Willems PHGM, Rossignol R, Dieteren CEJ, Murphy MP, and Koopman WJH. Redox homeostasis and mitochondrial dynamics. Cell Metab 22: 207–218, 2015 PubMed

Xu D, Guo H, Xu X, Lu Z, Fassett J, et al. . Exacerbated pulmonary arterial hypertension and right ventricular hypertrophy in animals with loss of function of extracellular superoxide dismutase. Hypertension 58: 303–309, 2011 PubMed PMC

Xu H. and Pearl RG. Effect of l-glutamine on pulmonary hypertension in the perfused rabbit lung. Pharmacology 48: 260–264, 1994 PubMed

Yang M. and Vousden KH. Serine and one-carbon metabolism in cancer. Nat Rev Cancer 16: 650–662, 2016 PubMed

Yao C, Yu J, Taylor L, Polgar P, McComb ME, and Costello CE. Protein expression by human pulmonary artery smooth muscle cells containing a BMPR2 mutation and the action of ET-1 as determined by proteomic mass spectrometry. Int J Mass Spectrom 378: 347–359, 2015 PubMed PMC

Yi W, Clark PM, Mason DE, Keenan MC, Hill C, et al. . Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science 337: 975–980, 2012 PubMed PMC

Zhang H, Wang D, Li M, Plecita L, D'Alessandro A, et al. . Using genetics, epigenetics and small molecules to reverse metabolic reprogramming in adventitia fibroblasts for pulmonary hypertension therapy. In: B53. PHOUND IN TRANSLATION. New York, NY: American Thoracic Society, 2016, p. A3895

Zhao L, Ashek A, Wang L, Fang W, Dabral S, et al. . Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments. Circulation 128: 1214–1224, 2013 PubMed

Zhao L, Chen C-N, Hajji N, Oliver E, Cotroneo E, et al. . Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid. Circulation 126: 455–467, 2012 PubMed PMC

Zhao Y, Peng J, Lu C, Hsin M, Mura M, et al. . Metabolomic heterogeneity of pulmonary arterial hypertension. PLoS One 9: e88727, 2014 PubMed PMC

Zhao YD, Chu L, Lin K, Granton E, Yin L, et al. . A biochemical approach to understand the pathogenesis of advanced pulmonary arterial hypertension: metabolomic profiles of arginine, sphingosine-1-phosphate, and heme of human lung. PLoS One 10: e0134958, 2015 PubMed PMC

Mechanisms Controlling the Behavior of Vascular Smooth Muscle Cells in Hypoxic Pulmonary Hypertension

SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension

Redox Signaling from Mitochondria: Signal Propagation and Its Targets

Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis